-+ 0.00%
-+ 0.00%
-+ 0.00%

ATAVISTIK BIO: RAISED $120MLN SERIES B FINANCING TO SUPPORT SELECTIVE ALLOSTERIC SMALL MOLECULE THERAPEUTICS ADVANCEMENT FOR HHT, MPNS TREATMENT

Reuters·12/18/2025 12:03:40

Please log in to view news